Annual FCF
$1.08 B
+$66.49 M+6.54%
December 1, 2024
Summary
- As of February 25, 2025, GMAB annual free cash flow is $1.08 billion, with the most recent change of +$66.49 million (+6.54%) on December 1, 2024.
- During the last 3 years, GMAB annual FCF has risen by +$768.96 million (+244.56%).
- GMAB annual FCF is now at all-time high.
Performance
GMAB Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
$353.01 M
+$51.48 M+17.07%
December 1, 2024
Summary
- As of February 25, 2025, GMAB quarterly free cash flow is $353.01 million, with the most recent change of +$51.48 million (+17.07%) on December 1, 2024.
- Over the past year, GMAB quarterly FCF has increased by +$51.48 million (+17.07%).
- GMAB quarterly FCF is now -56.36% below its all-time high of $808.85 million, reached on September 30, 2020.
Performance
GMAB Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
$1.08 B
+$124.56 M+12.99%
December 1, 2024
Summary
- As of February 25, 2025, GMAB TTM free cash flow is $1.08 billion, with the most recent change of +$124.56 million (+12.99%) on December 1, 2024.
- Over the past year, GMAB TTM FCF has increased by +$124.56 million (+12.99%).
- GMAB TTM FCF is now -3.25% below its all-time high of $1.12 billion, reached on September 30, 2020.
Performance
GMAB TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
GMAB Free Cash Flow Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +6.5% | +17.1% | +13.0% |
3 y3 years | +244.6% | +17.1% | +13.0% |
5 y5 years | +494.7% | +17.1% | +13.0% |
GMAB Free Cash Flow Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +244.6% | -21.8% | +1135.4% | at high | +423.8% |
5 y | 5-year | at high | +494.7% | -56.4% | +323.1% | -3.3% | +748.7% |
alltime | all time | at high | +419.6% | -56.4% | +323.1% | -3.3% | +1005.8% |
Genmab A/S Free Cash Flow History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2024 | $1.08 B(+6.5%) | $353.01 M(+17.1%) | $1.08 B(+13.0%) |
Sep 2024 | - | $301.53 M(+41.9%) | $958.82 M(+2.0%) |
Jun 2024 | - | $212.55 M(-1.7%) | $940.04 M(+20.3%) |
Mar 2024 | - | $216.30 M(-5.3%) | $781.65 M(-23.1%) |
Dec 2023 | $1.02 B(+99.5%) | $228.45 M(-19.2%) | $1.02 B(+19.6%) |
Sep 2023 | - | $282.75 M(+422.1%) | $850.36 M(+4.7%) |
Jun 2023 | - | $54.16 M(-88.0%) | $811.89 M(-7.9%) |
Mar 2023 | - | $451.53 M(+629.2%) | $881.21 M(+72.9%) |
Dec 2022 | $509.63 M(+62.1%) | $61.92 M(-74.7%) | $509.63 M(+7.0%) |
Sep 2022 | - | $244.28 M(+97.8%) | $476.29 M(+66.8%) |
Jun 2022 | - | $123.48 M(+54.4%) | $285.62 M(+38.1%) |
Mar 2022 | - | $79.95 M(+179.8%) | $206.82 M(-34.2%) |
Dec 2021 | $314.42 M(-66.5%) | $28.57 M(-46.7%) | $314.42 M(+146.3%) |
Sep 2021 | - | $53.61 M(+20.0%) | $127.65 M(-85.5%) |
Jun 2021 | - | $44.68 M(-76.2%) | $882.89 M(+3.6%) |
Mar 2021 | - | $187.56 M(-218.6%) | $852.18 M(-9.2%) |
Dec 2020 | $938.63 M(+415.2%) | -$158.20 M(-119.6%) | $938.63 M(-16.2%) |
Sep 2020 | - | $808.85 M(+5688.5%) | $1.12 B(+219.6%) |
Jun 2020 | - | $13.97 M(-94.9%) | $350.40 M(-2.9%) |
Mar 2020 | - | $274.00 M(+1094.7%) | $360.76 M(+98.0%) |
Dec 2019 | $182.18 M(+114.2%) | $22.93 M(-41.9%) | $182.18 M(-3.7%) |
Sep 2019 | - | $39.49 M(+62.3%) | $189.09 M(+62.3%) |
Jun 2019 | - | $24.33 M(-74.5%) | $116.51 M(+7.2%) |
Mar 2019 | - | $95.42 M(+219.8%) | $108.68 M(+27.8%) |
Dec 2018 | $85.06 M(-62.7%) | $29.84 M(-190.2%) | $85.06 M(+2.9%) |
Sep 2018 | - | -$33.09 M(-300.5%) | $82.66 M(-36.9%) |
Jun 2018 | - | $16.50 M(-77.0%) | $130.91 M(-32.2%) |
Mar 2018 | - | $71.81 M(+161.8%) | $192.97 M(-15.5%) |
Dec 2017 | $228.32 M(+421.4%) | $27.43 M(+81.0%) | $228.32 M(+23.4%) |
Sep 2017 | - | $15.16 M(-80.7%) | $185.09 M(-7.5%) |
Jun 2017 | - | $78.56 M(-26.7%) | $200.03 M(+30.9%) |
Mar 2017 | - | $107.17 M(-778.1%) | $152.84 M(+249.0%) |
Dec 2016 | $43.79 M | -$15.80 M(-152.5%) | $43.79 M(-53.8%) |
Sep 2016 | - | $30.10 M(-4.1%) | $94.74 M(+11.9%) |
Jun 2016 | - | $31.37 M(-1765.6%) | $84.68 M(+137.3%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2016 | - | -$1.88 M(-105.4%) | $35.69 M(+36.3%) |
Dec 2015 | $26.19 M(+156.6%) | $35.15 M(+75.4%) | $26.19 M(-436.7%) |
Sep 2015 | - | $20.04 M(-213.8%) | -$7.78 M(-67.0%) |
Jun 2015 | - | -$17.62 M(+54.8%) | -$23.54 M(-912.0%) |
Mar 2015 | - | -$11.38 M(-1068.1%) | $2.90 M(-71.6%) |
Dec 2014 | $10.21 M(-141.4%) | $1.18 M(-72.5%) | $10.21 M(+77.0%) |
Sep 2014 | - | $4.28 M(-51.5%) | $5.77 M(-171.6%) |
Jun 2014 | - | $8.82 M(-316.6%) | -$8.05 M(-62.5%) |
Mar 2014 | - | -$4.07 M(+24.7%) | -$21.44 M(-13.0%) |
Dec 2013 | -$24.64 M(-330.4%) | -$3.27 M(-65.7%) | -$24.64 M(-10.7%) |
Sep 2013 | - | -$9.53 M(+108.6%) | -$27.60 M(-212.4%) |
Jun 2013 | - | -$4.57 M(-37.2%) | $24.54 M(+56.6%) |
Mar 2013 | - | -$7.27 M(+16.8%) | $15.67 M(+46.5%) |
Dec 2012 | $10.69 M(-112.9%) | -$6.22 M(-114.6%) | $10.69 M(-352.6%) |
Sep 2012 | - | $42.61 M(-417.0%) | -$4.23 M(-93.6%) |
Jun 2012 | - | -$13.44 M(+9.8%) | -$66.41 M(-18.7%) |
Mar 2012 | - | -$12.25 M(-42.1%) | -$81.65 M(-1.6%) |
Dec 2011 | -$83.02 M(-280.7%) | -$21.15 M(+8.1%) | -$83.02 M(-3.4%) |
Sep 2011 | - | -$19.57 M(-31.8%) | -$85.93 M(-229.5%) |
Jun 2011 | - | -$28.69 M(+110.7%) | $66.34 M(-9.1%) |
Mar 2011 | - | -$13.62 M(-43.4%) | $72.97 M(+58.8%) |
Dec 2010 | $45.94 M(-141.8%) | -$24.06 M(-118.1%) | $45.94 M(-15.8%) |
Sep 2010 | - | $132.71 M(-701.6%) | $54.59 M(-145.6%) |
Jun 2010 | - | -$22.06 M(-45.7%) | -$119.60 M(+2.4%) |
Mar 2010 | - | -$40.64 M(+163.7%) | -$116.80 M(+6.3%) |
Dec 2009 | -$109.83 M(-67.6%) | -$15.41 M(-62.8%) | -$109.83 M(+16.3%) |
Sep 2009 | - | -$41.48 M(+115.4%) | -$94.41 M(+78.4%) |
Jun 2009 | - | -$19.26 M(-42.8%) | -$52.93 M(+57.2%) |
Mar 2009 | - | -$33.67 M | -$33.67 M |
Dec 2008 | -$338.97 M(-474.2%) | - | - |
Dec 2007 | $90.59 M(-241.0%) | - | - |
Dec 2006 | -$64.26 M(+82.3%) | - | - |
Dec 2005 | -$35.26 M(-43.9%) | - | - |
Dec 2004 | -$62.88 M(+30.3%) | - | - |
Dec 2003 | -$48.27 M(-7.3%) | - | - |
Dec 2002 | -$52.06 M | - | - |
FAQ
- What is Genmab A/S annual free cash flow?
- What is the all time high annual FCF for Genmab A/S?
- What is Genmab A/S annual FCF year-on-year change?
- What is Genmab A/S quarterly free cash flow?
- What is the all time high quarterly FCF for Genmab A/S?
- What is Genmab A/S quarterly FCF year-on-year change?
- What is Genmab A/S TTM free cash flow?
- What is the all time high TTM FCF for Genmab A/S?
- What is Genmab A/S TTM FCF year-on-year change?
What is Genmab A/S annual free cash flow?
The current annual FCF of GMAB is $1.08 B
What is the all time high annual FCF for Genmab A/S?
Genmab A/S all-time high annual free cash flow is $1.08 B
What is Genmab A/S annual FCF year-on-year change?
Over the past year, GMAB annual free cash flow has changed by +$66.49 M (+6.54%)
What is Genmab A/S quarterly free cash flow?
The current quarterly FCF of GMAB is $353.01 M
What is the all time high quarterly FCF for Genmab A/S?
Genmab A/S all-time high quarterly free cash flow is $808.85 M
What is Genmab A/S quarterly FCF year-on-year change?
Over the past year, GMAB quarterly free cash flow has changed by +$51.48 M (+17.07%)
What is Genmab A/S TTM free cash flow?
The current TTM FCF of GMAB is $1.08 B
What is the all time high TTM FCF for Genmab A/S?
Genmab A/S all-time high TTM free cash flow is $1.12 B
What is Genmab A/S TTM FCF year-on-year change?
Over the past year, GMAB TTM free cash flow has changed by +$124.56 M (+12.99%)